Background Psoriasis is associated with risk of cardiovascular (CV) disease (CVD) and a
major adverse CV event (MACE). Whether psoriasis duration affects risk of vascular …

Psoriasis is associated with considerable physical and psychological morbidity. Optimal use
of psoriasis treatments can limit the physical manifestations of psoriasis and help improve …

Structured clinical examination was performed for diagnosis and inclusion of the cases by
one of three dermatologists involved in the study. Each clinical examination resulted in …

Creation and maintenance of psoriatic plaques require a multicellular conspiracy by which
prepsoriatic skin becomes infiltrated by a variety of immunocytes triggering changes in the …

Objectives Both overall and central obesity have been associated with the risk of psoriasis in
a prospective study. Data on the association between obesity and psoriatic arthritis (PsA) …

Objective To assess the risk of incident diabetes mellitus (DM) in patients with psoriasis and
to evaluate DM treatment patterns among patients with psoriasis and incident DM. Design …

Obesity, particularly abdominal obesity, is currently considered a chronic low-grade
inflammatory condition that plays an active role in the development of the pathophysiologic …

Background Psoriasis is associated with an increased risk of atherosclerosis. This study
compared subclinical atherosclerosis of the carotid and brachial arteries in psoriasis …

Background C‐reactive protein (CRP), an inflammation biomarker, indicates cardiovascular
risk and is elevated in psoriasis. The effect of etanercept on CRP in psoriasis has not been …

Psoriasis is a common disease with the population prevalence ranging from 2% to 3%. Its
prevalence in the population is affected by genetic, environmental, viral, infectious …